These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 19959508

  • 1. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
    Prince MR, Zhang HL, Prowda JC, Grossman ME, Silvers DN.
    Radiographics; 2009 Oct; 29(6):1565-74. PubMed ID: 19959508
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for NSF: a literature review.
    Prince MR, Zhang HL, Roditi GH, Leiner T, Kucharczyk W.
    J Magn Reson Imaging; 2009 Dec; 30(6):1298-308. PubMed ID: 19937930
    [Abstract] [Full Text] [Related]

  • 3. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
    Weinreb JC, Abu-Alfa AK.
    J Magn Reson Imaging; 2009 Dec; 30(6):1236-9. PubMed ID: 19938035
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 6. Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
    Abu-Alfa AK.
    Adv Chronic Kidney Dis; 2011 May 01; 18(3):188-98. PubMed ID: 21531325
    [Abstract] [Full Text] [Related]

  • 7. Toxicity of contrast media: an update.
    ten Dam MA, Wetzels JF.
    Neth J Med; 2008 Nov 01; 66(10):416-22. PubMed ID: 19011267
    [Abstract] [Full Text] [Related]

  • 8. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
    Kribben A, Witzke O, Hillen U, Barkhausen J, Daul AE, Erbel R.
    J Am Coll Cardiol; 2009 May 05; 53(18):1621-8. PubMed ID: 19406336
    [Abstract] [Full Text] [Related]

  • 9. Nephrogenic systemic fibrosis and management of high-risk patients.
    Altun E, Semelka RC, Cakit C.
    Acad Radiol; 2009 Jul 05; 16(7):897-905. PubMed ID: 19375360
    [Abstract] [Full Text] [Related]

  • 10. Nephrogenic systemic fibrosis and the role of gadolinium contrast media.
    van der Molen AJ.
    J Med Imaging Radiat Oncol; 2008 Aug 05; 52(4):339-50. PubMed ID: 18811757
    [Abstract] [Full Text] [Related]

  • 11. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
    Wiginton CD, Kelly B, Oto A, Jesse M, Aristimuno P, Ernst R, Chaljub G.
    AJR Am J Roentgenol; 2008 Apr 05; 190(4):1060-8. PubMed ID: 18356456
    [Abstract] [Full Text] [Related]

  • 12. Nephrogenic systemic fibrosis: clinical picture and treatment.
    Marckmann P, Skov L.
    Radiol Clin North Am; 2009 Sep 05; 47(5):833-40, vi. PubMed ID: 19744598
    [Abstract] [Full Text] [Related]

  • 13. Gadolinium-based contrast agents and NSF: evidence from animal experience.
    Sieber MA, Steger-Hartmann T, Lengsfeld P, Pietsch H.
    J Magn Reson Imaging; 2009 Dec 05; 30(6):1268-76. PubMed ID: 19938039
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
    Peak AS, Sheller A.
    Ann Pharmacother; 2007 Sep 05; 41(9):1481-5. PubMed ID: 17684032
    [Abstract] [Full Text] [Related]

  • 15. Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case-control study from Denmark.
    Elmholdt TR, Pedersen M, Jørgensen B, Søndergaard K, Jensen JD, Ramsing M, Olesen AB.
    Br J Dermatol; 2011 Oct 05; 165(4):828-36. PubMed ID: 21692765
    [Abstract] [Full Text] [Related]

  • 16. Removal of gadolinium by dialysis: review of different strategies and techniques.
    Silberzweig JI, Chung M.
    J Magn Reson Imaging; 2009 Dec 05; 30(6):1347-9. PubMed ID: 19937933
    [Abstract] [Full Text] [Related]

  • 17. Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases.
    Zou Z, Zhang HL, Roditi GH, Leiner T, Kucharczyk W, Prince MR.
    JACC Cardiovasc Imaging; 2011 Nov 05; 4(11):1206-16. PubMed ID: 22093272
    [Abstract] [Full Text] [Related]

  • 18. Guideline to use gadolinium-based contrast agents at Kyoto University Hospital.
    Miki Y, Isoda H, Togashi K.
    J Magn Reson Imaging; 2009 Dec 05; 30(6):1364-5. PubMed ID: 19937936
    [Abstract] [Full Text] [Related]

  • 19. [Nephrogenic systemic fibrosis].
    Breitschaft A, Stahlmann R.
    Med Monatsschr Pharm; 2009 Oct 05; 32(10):377-82. PubMed ID: 19886227
    [Abstract] [Full Text] [Related]

  • 20. How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States.
    Thomsen HS.
    Radiol Clin North Am; 2009 Sep 05; 47(5):871-5, vii. PubMed ID: 19744601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.